Evaluación de la adherencia y de los resultados en salud en trasplante alogénico de progenitores hematopoyéticos

García-Basas, Lorena; Sánchez-Cuervo, Marina; Gómez de Salazar-López de Silanes, Esther; Pueyo-López, Cristina; Núñez-Torrón-Stock, Claudia; Herrera-Puente, Pilar.
Farm. hosp ; 44(3): 87-91, mayo-jun. 2020. tab
Artigo em Espanhol | IBECS (Espanha) | ID: ibc-192339

Documentos relacionados

  1. Evaluation of adherence and clinical outcomes in patients undergoing allogeneic haematopoietic stem cell transplantation.
  2. [Efficacy evaluation of 0.05% cyclosporine A and 0.1% tacrolimus eye drops in the treatment of severe dry eye associated with chronic graft-versus-host disease].
  3. Progress and challenges in the biofoundry of immunosuppressants: From process to practice.
  4. Effect of Itraconazole and Its Metabolite Hydroxyitraconazole on the Blood Concentrations of Cyclosporine and Tacrolimus in Lung Transplant Recipients.
  5. Randomized trial of 3 maintenance regimens (TAC/SRL vs. TAC/MMF vs. CSA/SRL) with low-dose corticosteroids in primary kidney transplantation: 18-year results.
  6. Comparison of tacrolimus vs. cyclosporine in pediatric hematopoietic stem cell transplantation for thalassemia.
  7. Analyzing the clinical outcomes of switching from cyclosporine to tacrolimus in pediatric hematopoietic stem cell transplantation.
  8. Comparative effects of fluconazole, posaconazole, and isavuconazole upon tacrolimus and cyclosporine serum concentrations.
  9. A prospective randomized trial comparing cyclosporine/methotrexate and tacrolimus/sirolimus as graft-versus-host disease prophylaxis after allogeneic hematopoietic stem cell transplantation.
  10. Applying propensity methods to the United States transplant registry for external real-world evidence control arms for 5-year survival in the BENEFIT study.